Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted …

M Liao, R Qin, W Huang, HP Zhu, F Peng… - Journal of Hematology & …, 2022 - Springer
Triple-negative breast cancer (TNBC) is a subtype of human breast cancer with one of the
worst prognoses, with no targeted therapeutic strategies currently available. Regulated cell …

Autophagy-dependent cell death–where, how and why a cell eats itself to death

S Bialik, SK Dasari, A Kimchi - Journal of cell science, 2018 - journals.biologists.com
Autophagy as a means of cell killing was first advanced by Clark's phenotypic description of
'Type II autophagic cell death'in 1990. However, this phenomenon later came into question …

Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744) …

GS Sheppard, L Wang, SD Fidanze… - Journal of Medicinal …, 2020 - ACS Publications
The BET family of proteins consists of BRD2, BRD3, BRD4, and BRDt. Each protein contains
two distinct bromodomains (BD1 and BD2). BET family bromodomain inhibitors under …

Small-molecule drug discovery in triple negative breast cancer: current situation and future directions

M Liao, J Zhang, G Wang, L Wang, J Liu… - Journal of medicinal …, 2021 - ACS Publications
Triple negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, but
an effective targeted therapy has not been well-established so far. Considering the lack of …

Targeting Brd4 for cancer therapy: inhibitors and degraders

Y Duan, Y Guan, W Qin, X Zhai, B Yu, H Liu - Medchemcomm, 2018 - pubs.rsc.org
Bromodomain-containing protein 4 (Brd4) plays an important role in mediating the
expression of genes involved in cancers and non-cancer diseases such as inflammatory …

Targeting bromodomain-selective inhibitors of BET proteins in drug discovery and development

J Chen, P Tang, Y Wang, J Wang, C Yang… - Journal of medicinal …, 2022 - ACS Publications
Blocking the interactions between bromodomain and extraterminal (BET) proteins and
acetylated lysines of histones by small molecules has important implications for the …

Regulation of programmed cell death by Brd4

J Hu, D Pan, G Li, K Chen, X Hu - Cell Death & Disease, 2022 - nature.com
Epigenetic factor Brd4 has emerged as a key regulator of cancer cell proliferation. Targeted
inhibition of Brd4 suppresses growth and induces apoptosis of various cancer cells. In …

Discovery of Thieno[2,3-d]pyrimidine-Based Hydroxamic Acid Derivatives as Bromodomain-Containing Protein 4/Histone Deacetylase Dual Inhibitors Induce …

Z Pan, X Li, Y Wang, Q Jiang, L Jiang… - Journal of medicinal …, 2020 - ACS Publications
Bromodomain-containing protein 4 (BRD4) and histone deacetylases (HDAC) are both
attractive epigenetic targets in cancer and other chronic diseases. Based on the integrated …

[HTML][HTML] Paecilomyces cicadae-fermented Radix astragali activates podocyte autophagy by attenuating PI3K/AKT/mTOR pathways to protect against diabetic …

F Yang, Q Qu, C Zhao, X Liu, P Yang, Z Li, L Han… - Biomedicine & …, 2020 - Elsevier
Radix astragali, a medicinal material for tonifying Chinese Qi, has widely been used for the
treatment of Kidney disease in China and East Asia, especially in reducing the apoptosis of …

Dual-target inhibitors of indoleamine 2, 3 dioxygenase 1 (Ido1): A promising direction in cancer immunotherapy

Y Zhang, Z Hu, J Zhang, C Ren, Y Wang - European Journal of Medicinal …, 2022 - Elsevier
Abstract Indoleamine 2, 3-dioxygenase 1 (IDO1) is a rate-limiting enzyme that catalyzes the
kynurenine (Kyn) pathway of tryptophan metabolism in the first step, and the kynurenine …